Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 14/20 | 0.90 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL3750566 | 0.94 | HTR6 (0.78) | HTR6KCNH2MAPTPOLBSMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL3749727 | 0.84 | HTR6 (0.63) | HTR6KCNH2MAPTSMN1; SMN2KDM4E | |
| Trifluoroacetic Acid SCHEMBL3759673 | 0.83 | HTR6 (0.88) | HTR6KCNH2SMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL3756951 | 0.82 | HTR6 (0.64) | HTR6KCNH2SMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL3754757 | 0.81 | HTR6 (0.89) | HTR6KCNH2SMN1; SMN2KDM4E | |
| SCHEMBL3761881 | 0.81 | HTR6 (0.81) | HTR6KCNH2SMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL3747534 | 0.81 | HTR6 (0.63) | HTR6KCNH2SMN1; SMN2KDM4E | |
| SCHEMBL3742336 | 0.79 | HTR6 (1.00) | HTR6KCNH2SMN1; SMN2 | |
| SCHEMBL3754246 | 0.78 | HTR6 (0.77) | HTR6KCNH2 | |
| SCHEMBL3744515 | 0.77 | HTR6 (0.74) | HTR6KCNH2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7838518-B2 | 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders | N.V. ORGANON (NL) | 2010-11-23 | — | — | US | disclosed |
| EP-1476151-B1 | 1-ARYLSULFONYL-3-SUBSTITUED INDOLE AND INDOLINE DERIVATES USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | ORGANON NV (NL) | 2008-07-16 | — | — | EP | disclosed |